Stay updated on Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.

Latest updates to the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No study details or page functionality were changed.SummaryDifference0.0%

- Check23 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1 with no visible changes to study content, layout, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 in the site footer. This is a minor housekeeping update with no impact on content or features.SummaryDifference0.0%

- Check67 days agoChange DetectedLocations section now lists state-specific sites (Alabama, California, Colorado, Illinois, Maryland, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Washington) and the page revision is v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check96 days agoChange DetectedPubMed publication listing text was updated and the footer revision number was changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedRemoved the general government funding operating status notice from the page; the study details and other content remain unchanged.SummaryDifference0.3%

Stay in the know with updates to Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.